WuXi Biologics’ third site: First batch done, US client next
WuXi Biologics completed its first manufacturing project at its 200,000 sq. ft. facility in Wuxi City earlier this week.
WuXi Biologics completed its first manufacturing project at its 200,000 sq. ft. facility in Wuxi City earlier this week.
The multi-year project with an unnamed pharmaceutical company will use the macaque monkey as a developmental model for progressive brain disorders and is valued at more than $1m.
Pfizer has revealed it will invest $5bn to support operations in the US, with the first step being the construction of a 400,000-square-foot production facility, costing $465m.
ACG has expanded its capabilities by completing its work on a lamination facility to be able to complete all packaging requirements for solid oral medication in-house.
Pan-American countries should adopt EMA-style regulations to increase clinical trial transparency and streamline research, according to a recent report.
Using thermosensitive liposomes and ultrasound, researchers were able to boost drug concentration in patient tumours ten-fold.